Asymchem

6821
114.4003.62% ( -4.300 )
Delay Closed: Nov 16, 16:08:11

Overview

Asymchem (6821)

Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization (CDMO) solutions in Mainland China and internationally. I...

Open
116.800
High
117.800
Low
112.400
Prev. Close
118.700
Volume
456.00K
Turnover
52.23M
Avg Price
114.545
Bid/Ask Ratio
23.08%
Amplitude
4.55%
52wk High
178.000
Volume Ratio
0.49
Turnover Ratio
1.64%
52wk Low
67.705
HK Mkt Cap
3.18B
Market CapHKD
41.41B
P/ETTM
30.01
P/EDynamic
31.28
P/EStatic
--
EPSTTM
3.81
EPSDynamic
3.66
EPSStatic
--
BVPS
57.31
P/B
2.00
HK Shares
27.83M
Dividend YieldTTM
1.30%
DividendTTM
1.491
Shares
361.95M
Min lot size
100
Currency
HKD

Asymchem Analyst Rating

View more

Forecast & Rating

Nov 9, 2026
Price forecast
HK$154.1434.74%
Forecast & RatingBuy
8analysts
  • Strong buy50.00%
  • Buy37.50%
  • Hold12.50%
  • Sell0.00%
  • Strong sell0.00%

Daily Events

  1. Jul, 3

    Benefiting from China's launch of a new round of drug procurement and a sentiment boost in the CXO sector, Asymchem surged 11.5% today after a low open, hitting an intraday high of HKD 119.5 in the afternoon session before closing at HKD 118.7. News-wise, the company unveiled its fully integrated TIDES commercial supply matrix, with Goldman Sachs, BOCOM International, and CMBC International reaffirming Buy ratings, while brokerages highlighted the CDMO industry's resilience. Financially, Q1 revenue rose 23.8% YoY to HKD 2.04 billion, though net profit edged down 1.4% YoY; net profit margin modestly improved to 16.9% from 16.3% in Q4. The stock is now just 4.6% below its 52-week high of HKD 124.4, with a YTD gain of 61.3%, and trades well above MA20 (HKD 98.9) and MA60 (HKD 98.5), indicating elevated valuation. However, today's volume of 771,840 shares was lower than the prior session, suggesting limited chase momentum.

News

Bullish vs. Bearish — Last 3 Months

2.7k followers · 0 opinions
▲Bullish50%
50%Bearish▼